Does TELMISARTAN Cause Affect lability? 11 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Affect lability have been filed in association with TELMISARTAN (telmisartan). This represents 0.2% of all adverse event reports for TELMISARTAN.
11
Reports of Affect lability with TELMISARTAN
0.2%
of all TELMISARTAN reports
0
Deaths
11
Hospitalizations
How Dangerous Is Affect lability From TELMISARTAN?
Of the 11 reports, 11 (100.0%) required hospitalization.
Is Affect lability Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TELMISARTAN. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does TELMISARTAN Cause?
Drug ineffective (685)
Dizziness (569)
Dyspnoea (556)
Headache (508)
Fall (500)
Nausea (486)
Hypertension (477)
Blood pressure increased (473)
Diarrhoea (467)
Malaise (458)
What Other Drugs Cause Affect lability?
DULOXETINE (2,510)
METFORMIN (291)
AMLODIPINE (274)
METHOTREXATE (266)
ATORVASTATIN (259)
IRBESARTAN (257)
LEVOTHYROXINE (251)
SITAGLIPTIN (244)
ESOMEPRAZOLE (234)
ASPIRIN (224)
Which TELMISARTAN Alternatives Have Lower Affect lability Risk?
TELMISARTAN vs TELOTRISTAT ETHYL
TELMISARTAN vs TEMAZEPAM
TELMISARTAN vs TEMODAR
TELMISARTAN vs TEMOZOLOMIDE
TELMISARTAN vs TEMSIROLIMUS